Cite
MLA Citation
M. Dimopoulos et al.. “P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM).” HemaSphere, vol. 6, n.d., pp. 1048–1049. http://access.bl.uk/ark:/81055/vdc_100159756984.0x000015